CBX2 functions as a potent tumor accelerator in BC, promoting tumorigenesis through multiple pathways including the PI3K/AKT signaling pathway, metabolic reprogramming, and intronic DNA methylation, which possibly mainly attribute to regulation of gene expression at chromatin [25, 34–36]. The gene discussed is AKT1; the disease is breast cancer.